Breaking

Crypto Market Update: Altcoins Retreat as Bitcoin ETFs See US$2.7 Billion in Inflows
Tech Weekly: Market Dives After Week-Long Rally as China/US Tensions Reignite
Editor’s Picks: Historic Week — Gold Breaks US$4,000, Silver Takes Out All-time High
Top 5 Canadian Mining Stocks This Week: Valhalla Jumps 282 Percent on Ambler Approval
SAGA Metals Announces Closing of Fully Subscribed Non-Brokered Private Placement and Provides Corporate Update
China outlines more controls on exports of rare earths and technology
Locksley Resources Limited400% Increase in Antimony Target Strike Length
400% Increase in Antimony Target Strike Length

Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

June 4, 2025 Investing 1 Min Read

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Operational Update

Top

Type above and press Enter to search. Press Esc to cancel.